Home » Topics » BioWorld Science

BioWorld Science
RSS

New triple-modal nanoparticle therapy overcomes drug resistance in bladder cancer models

Aug. 11, 2020

Phase IIa study of KY-1005 in atopic dermatitis meets primary endpoints

Aug. 11, 2020

Phase III data show ensartinib significantly prolongs PFS over crizotinib in ALK-positive NSCLC

Aug. 11, 2020

Positive interim data presented from EQUATE study of itolizumab in acute GvHD

Aug. 11, 2020

IDMC recommends continuation of phase IIb trial of XF-73 for postsurgical bacterial infections

Aug. 11, 2020

FDA gives may proceed notice for phase IIb/III study of SLS-005 in ALS

Aug. 11, 2020

AnaptysBio reports interim analysis data from ECLIPSE phase II study of etokimab

Aug. 11, 2020

HitGen patents STING agonists

Aug. 11, 2020

New RIP-1 kinase 1 inhibitors synthesized at Beijing Scitech-Mq Pharmaceuticals

Aug. 11, 2020

Abbisko Therapeutics discloses Nuclear receptor RORgammaT agonists

Aug. 11, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...